u/ignacio_vanhecke

AU or NZ?

Small correction: the trial was 2 weeks, not 31. Does not change your point but people will quote it.

copay is separate from coverage

Yes, exactly this, and it is the bit that took me 14 weeks to accept.

resubmission after denial requires new documentation

the New Zealand import rules are specific to New Zealand

The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.

Small correction: the trial was 3 weeks, not 24. Does not change your point but people will quote it.

The related substances profile is way more interesting than the main peak %. A 98% with 22 peaks is different from a 98% that is one 17% impurity.

co-elution is real and method development is usually not enough to resolve it

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the 13mg import allowance is New Zealand-specific

the muscle cramps from tirz is different, not necessarily worse

no pharmacy referral codes, naming is fine, recruiting is not

Strongly agree. Step therapy is predictable if you have the criteria.

state the method: column, gradient, detection wavelength, injection volume

unfunded-means-full-price is the NZ reality

A shoulder on the main peak that 9 analysts integrated 17 different ways. Same trace, 98.0 spread.

step therapy documentation is the weapon, use it

Do you have an import allowance in your jurisdiction?

Did they post the raw trace or just the summary?

Sceptical. If this were true we would see it reflected in the data and we do not.